Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Hepatology

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.510240606PMID 8938160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region

  2005cited by this paper
• Quantitation of hepatitis C virus RNA.

  1996cited by this paper
• Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

  1995cited by this paper
• Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

  1995cited by this paper
• Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features

  1995cited by this paper
• Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization.

  1994cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Typing of hepatitis C virus isolates by DNA enzyme immunoassay.

  1994cited by this paper
• Quantitation of hepatitis C virus RNA in liver transplant recipients.

  1994cited by this paper
• Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.

  1994cited by this paper
• Quantitation of hepatitis C virus RNA in liver transplant recipients

  1994cited by this paper
• Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization

  1994cited by this paper
• Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

  1993cited by this paper
• Recurrent and acquired hepatitis C viral infection in liver transplant recipients.

  1992cited by this paper
• Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction

  1992cited by this paper
• Hepatitis C virus reinfection in allografts after orthotopic liver transplantation

  1992cited by this paper
• Hepatitis C viral infection in liver transplant recipients

  1992cited by this paper
• Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.

  1992cited by this paper
• Isolation of a complementary DNA fragment of hepatitis C virus in Taiwan revealed significant sequence variations compared with other isolates

  1991cited by this paper
• Early events in hepatitis C virus infection of chimpanzees.

  1990cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper

• Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream

  2022cites this paper
• Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance

  2021cites this paper
• Fungal Lipases: Insights into Molecular Structures and Biotechnological Applications in Medicine and Dairy Industry

  2021cites this paper
• Overview of Immobilized Enzymes' Applications in Pharmaceutical, Chemical, and Food Industry.

  2020cites this paper
• Industrial applications of immobilized enzymes—A review

  2019cites this paper
• Risk factors of hepatic graft failure, morbidity and mortality after living donor liver transplantation (LDLT): Review Article

  2018cites this paper
• Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs

  2018cites this paper
• Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C–positive recipients

  2017cites this paper
• Outcome after living donor liver transplantation: A comprehensive retrospective analysis of the risk factors for morbidity, mortality and graft failure in a tertiary care center

  2017cites this paper
• Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe.

  2017cites this paper
• Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation.

  2016cites this paper
• Hepatitis C virus and liver transplantation: where do we stand?

  2016cites this paper
• Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma

  2016cites this paper
• Chapter 85 – Pathology of NonNeoplastic Disease After Transplantation

  2015cites this paper
• Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

  2015cites this paper
• INFLUENCIA DE LOS POLIMORFISMOS GENÉTICOS DE LOS RECEPTORES "TOLL-LIKE" EN LA GRAVEDAD DE LA RECIDIVA VIRAL Y EN LA INCIDENCIA DEL RECHAZO AGUDO EN PACIENTES CON TRASPLANTE HEPÁTICO POR CIRROSIS POR EL VIRUS DE LA HEPATITIS C

  2014cites this paper
• Maternal-fetal transmission of hepatitis C infection: what is so special about babies?

  2014cites this paper
• Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

  2014cites this paper
• The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence

  2014cites this paper
• Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients.

  2014cites this paper
• Infections in Liver, Kidney, Pancreas, and Intestinal Transplant Recipients

  2013cites this paper
• Completely steroid‐free immunosuppression in liver transplantation: a randomized study

  2013cites this paper
• Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System

  2013cites this paper
• Novel Agents Inhibiting Hepatitis C Virus; Application to Prevention of Re-infection after Liver Transplantation

  2013cites this paper
• Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.

  2013cites this paper
• Investigation of PEG-PLGA-PEG Nanoparticles-based Multipolyplexes for IL-18 Gene Delivery

  2012cites this paper
• Management of Hepatitis C Infection after Liver Transplantation

  2012cites this paper
• Early viral load and recipient interleukin‐28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation

  2012cites this paper
• Treatment of Hepatitis C in Solid Organ Transplantation

  2012cites this paper
• Pathology of liver transplantation

  2011cites this paper
• Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

  2011cites this paper
• Clinicopathological features of hepatitis C virus disease after living donor liver transplantation: relationship with in situ hybridisation data

  2011cites this paper
• Liver Transplantation for Hepatitis C: Disease Management

  2011cites this paper
• Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence

  2011cites this paper
• Impact of HCV genetic differences on pathobiology of disease

  2011cites this paper
• Human Liver Transplantation As A Model To Study HCV Pathogenesis

  2011cites this paper
• Optimizing use of basiliximab in liver transplantation

  2010cites this paper
• Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy.

  2010cites this paper
• Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease : A break of intestinal insulin resistance ?

  2010cites this paper
• Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains.

  2010cites this paper
• Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression

  2010cites this paper
• Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues

  2009cites this paper
• Defining the mechanism(s) of Hepatitis C virus (HCV) entry

  2009cites this paper
• Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp).

  2009cites this paper
• Treatment of recurrent hepatitis C virus infection in patients after liver transplantation

  2009cites this paper
• Liver Transplantation: The Current Situation

  2009cites this paper
• Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.

  2009cites this paper
• Liver transplantation: the current situation.

  2009cites this paper
• Hepatitis-B- und -C-Reinfektion: Prophylaxe und Therapie

  2009cites this paper
• Human liver transplantation as a model to study hepatitis C virus pathogenesis

  2009cites this paper
• In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation.

  2008cites this paper
• Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.

  2008cites this paper
• The natural history of recurrent hepatitis C and what influences this

  2008cites this paper
• Histoire naturelle, prévention et traitement de l'hépatite C après transplantation hépatique

  2008cites this paper
• Klinik und Poliklinik für Hepatobiliäre Chirurgie und Transplantationschirurgie des Universitätsklinikums Hamburg-Eppendorf

  2008cites this paper
• Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party

  2007cites this paper
• Viral dynamics in transplant patients: implications for disease.

  2007cites this paper
• Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin

  2007cites this paper
• [Treatment of recurrent hepatitis C virus infection after liver transplantation].

  2007cites this paper
• Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

  2007cites this paper
• Review article: the treatment of hepatitis C virus recurrence after liver transplantation

  2007cites this paper
• Impact of Steroids on Hepatitis C Virus Replication in Vivo and in Vitro

  2007cites this paper
• Update on liver transplantation: indications, organ allocation, and long-term care.

  2006cites this paper
• Perioperative viral kinetics: New insights or the Emperor's new clothes?

  2006cites this paper
• Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.

  2006cites this paper
• Detection of HCV antigens in liver graft: Relevance to the management of recurrent post‐liver transplant hepatitis C

  2006cites this paper
• HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?

  2006cites this paper
• Management of recurrent hepatitis C in liver transplant recipients.

  2006cites this paper
• Kinetics of hepatitis C virus reinfection after liver transplantation

  2006influential citation
• HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation.

  2006cites this paper
• The liver transplant recipient: what you need to know for long-term care.

  2006cites this paper
• Monoclonal Antibody AP 33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E 2 Envelope Glycoprotein

  2005cites this paper
• RECURRENCIA DE LA INFECCIÓN POR EL VIRUS DE LA HEPATITIS C (VHC) TRAS EL TRASPLANTE HEPÁTICO:FACTORES PREDICTIVOS DE RECIDIVA PRECOZ Y GRAVE.

  2005cites this paper
• Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

  2005cites this paper
• Management of hepatitis C virus infection in the setting of liver transplantation

  2005cites this paper
• Induction therapy with either anti‐CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C

  2005cites this paper
• Treatment of recurrent hepatitis C after liver transplantation.

  2005cites this paper
• Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

  2005cites this paper
• Alpha Glutationa S Transferase: marcador de lesão hepática em pacientes com hepatite pelo vírus C?

  2005cites this paper
• 70 – Pathology of Recurrence of Non-Neoplastic Disease After Liver Transplantation

  2005cites this paper
• Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.

  2005cites this paper
• Human leukocyte antigen phenotypes and hepatitis C viral load.

  2005cites this paper
• Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

  2005cites this paper
• Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

  2005cites this paper
• Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation

  2004cites this paper
• Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults

  2004cites this paper
• Advances in liver transplantation

  2004cites this paper
• Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

  2004cites this paper
• Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control.

  2004cites this paper
• Natural history of hepatitis C following liver transplantation

  2004cites this paper
• Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence

  2003cites this paper
• Outcome and management of hepatitis C in liver transplant recipients.

  2003cites this paper
• Immunosuppression in hepatitis B virus and hepatitis C virus transplants: special considerations.

  2003cites this paper
• Controversies in the management of hepatitis C virus infection after liver transplantation

  2003cites this paper
• Prophylactic and preemptive therapies for hepatitis C virus‐infected patients undergoing liver transplantation

  2003cites this paper
• Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis

  2003cites this paper
• Lebertransplantation — Indikationen, Vorbereitung und Nachsorge

  2003cites this paper
• Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel

  2003cites this paper
• Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation

  2003cites this paper
• Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.

  2003cites this paper